Anti-Cyclic Citrullinated Peptide Antibody: An Early Diagnostic and Prognostic Biomarker of Rheumatoid Arthritis

Dimensions

Manivelavan, D. (2012) Anti-Cyclic Citrullinated Peptide Antibody: An Early Diagnostic and Prognostic Biomarker of Rheumatoid Arthritis. JOURNAL FOR CLINICAL AND DIAGNOSTIC RESEARCH. ISSN 2249782X

Full text not available from this repository.

Abstract

This study assessed the role of Anti-Cyclic Citrullinated Peptide (anti-CCP) antibodies and Rheumatoid Factor (RF) in 60 RA patients. Anti-CCP showed superior detection capability compared to RF and independently predicted radiological damage and disease progression. Anti-CCP antibodies also distinguished erosive from non-erosive RA, proving to be a valuable prognostic marker. © 2012 Elsevier B.V., All rights reserved.

Item Type: Article
Subjects: Medicine > Rheumatology
Divisions: Medicine > Vinayaka Mission's Kirupananda Variyar Medical College and Hospital, Salem
Depositing User: Unnamed user with email techsupport@mosys.org
Last Modified: 10 Dec 2025 07:07
URI: https://vmuir.mosys.org/id/eprint/4382

Actions (login required)

View Item
View Item